142 related articles for article (PubMed ID: 29420362)
1. Malignant Endometrial Polyps in Uterine Serous Carcinoma: The Prognostic Value of Polyp Size and Lymphovascular Invasion.
Ouyang C; Frimer M; Hou LY; Wang Y; Goldberg GL; Hou JY
Int J Gynecol Cancer; 2018 Mar; 28(3):524-528. PubMed ID: 29420362
[TBL] [Abstract][Full Text] [Related]
2. Minimal uterine serous carcinoma and endometrial polyp: a close clinicopathological relationship.
Assem H; Rottmann D; Finkelstein A; Wang M; Ratner E; Santin AD; Buza N; Hui P
Hum Pathol; 2021 Dec; 118():1-8. PubMed ID: 34508766
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.
Semaan A; Mert I; Munkarah AR; Bandyopadhyay S; Mahdi HS; Winer IS; Nucci MR; Hussein Y; Quershi F; Hayek K; Tabassum F; Alosh B; Schultz DS; Cote ML; Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
Int J Gynecol Pathol; 2013 Mar; 32(2):181-7. PubMed ID: 23370657
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
6. Stage IA uterine serous carcinoma: a study of 13 cases.
Carcangiu ML; Tan LK; Chambers JT
Am J Surg Pathol; 1997 Dec; 21(12):1507-14. PubMed ID: 9414196
[TBL] [Abstract][Full Text] [Related]
7. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
[TBL] [Abstract][Full Text] [Related]
9. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
Childs AJ; Burke JJ; Perry MY; Gallup DG
J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
[TBL] [Abstract][Full Text] [Related]
11. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
McCluggage WG; Sumathi VP; McManus DT
Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Polyp in Postmenopausal Women: An Epicenter for the Development of Endometrial Serous Carcinoma.
Hui P
Arch Pathol Lab Med; 2023 Apr; 147(4):413-417. PubMed ID: 35512230
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
14. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
15. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
[TBL] [Abstract][Full Text] [Related]
16. Is the two-tier ovarian serous carcinoma grading system potentially useful in stratifying uterine serous carcinoma? A large multi-institutional analysis.
Ahmed Q; Hussein Y; Hayek K; Bandyopadhyay S; Semaan A; Abdul-Karim F; Al-Wahab Z; Munkarah AR; Elshaikh MA; Alosh B; Nucci MR; Van de Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
Gynecol Oncol; 2014 Feb; 132(2):372-6. PubMed ID: 24262874
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors of Uterine Serous Carcinoma-A Multicenter Study.
Zhong X; Wang J; Kaku T; Wang Z; Li X; Wei L
Int J Gynecol Cancer; 2018 Jul; 28(6):1138-1144. PubMed ID: 29621127
[TBL] [Abstract][Full Text] [Related]
18. Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?
Winer I; Ahmed QF; Mert I; Bandyopadhyay S; Cote M; Munkarah AR; Hussein Y; Al-Wahab Z; Elshaikh MA; Alosh B; Schultz DS; Mahdi H; Nucci MR; Van de Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
Int J Gynecol Pathol; 2015 Jan; 34(1):47-56. PubMed ID: 25473753
[TBL] [Abstract][Full Text] [Related]
19. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
20. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.
Hui P; Kelly M; O'Malley DM; Tavassoli F; Schwartz PE
Mod Pathol; 2005 Jan; 18(1):75-82. PubMed ID: 15389257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
